Ⅱ. MANUSCRIPT PREPARATION 1. Cover letter
The cover letter should include information on the corresponding author (the corresponding author's name, affiliation and address, telephone/fax numbers, and e-mail address).
As for Communications, please indicate in the cover letter the reason why the manuscript should be treated as a Communication.
Manuscript
The text, figures, and tables should be submitted as three separate files or one file. These are automatically incorporated into a single PDF that the system creates for review. Please use Times New Roman font in 12-point size for Word files. All files should have a page setup for A4-sized (210 mm wide × 297 mm high) paper when printed. Tables can be displayed horizontally if necessary.
(1) Title page The title page (page 1) should start with the journal name (Chem. Pharm. Bull.) and type of manuscript (Communication, Regular Article, etc.) . This should be followed by the title, name(s) of the author(s), affiliation(s), and mailing address(es). Please indicate the corresponding author's e-mail address in the footnote. An asterisk (*) should be added to the right of the corresponding author's name. Use a dagger ( †) to the right of a name to indicate that the present affiliation of an author is different to that of when the paper was written. In the footnotes, show the author's current affiliation and address.
(2) Summary and Keywords Page 2 should contain a summary no longer than 250 words as well as 3 to 6 descriptive keywords, listed in decreasing order of importance. The first 3 keywords must be independent, as they will be used in a keyword combination in the index (within 80 characters). Abbreviations should not be used as keywords.
(3) Main text
The text, acknowledgments, conflict of interest, and references should be presented in this order.
Graphical Abstracts
The graphical abstract, which authors must supply at the time the manuscript is first submitted, is presented in the Table of Contents so that readers can grasp the outline of the manuscript at a glance. Graphical abstracts should consist of carefully drawn figures (chemical structures, charts, graphs, images, or other informative illustrations) that show the most striking feature of the article in a pictorial form. Appropriate text may be included in the illustration. The illustration should be no larger than 100 mm wide × 40 mm high. The use of color to enhance the value and quality of the graphic is encouraged since they will be printed in color.
Supplementary materials
If an article has some supplementary materials, the author(s) should state it between Conflict of Interest and References: "The online version of this article contains supplementary materials."
Additional information for review
Other data necessary for review may be submitted as additional information. Additional information will not be published in the journal.
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Affiliations
When there are two or more authors and they belong to more than one affiliation, the connection between each author and his or her affiliation should be indicated by italicized superscripts a, b, c… placed after each author's name and before each affiliation.
Examples for describing affiliations and mailing addresses: 
Abbreviations
Abbreviations must be spelled out in full at their initial appearance each in the summary and the main text, followed by the abbreviation in parentheses. Thereafter, the abbreviation only may be used. Please limit to a minimum the use of abbreviations in the title. However, the following need not be defined: ADP (adenosine 5′-diphosphate), AIDS (acquired immunodefi-ciency syndrome), AMP (adenosine 5′-monophosphate or adenylic acid), ANOVA (analysis of variance), ATP (adenosine 5′-triphosphate), cAMP (adenosine 3′,5′-cyclic monophosphate), cDNA (complementary DNA), CoA (coenzyme A), CYP (cytochrome P450), DNA (deoxyribonucleic acid), ED 50 (50% effective dose), ESR (electron spin resonance), FAB-MS (fast atom bombardment mass spectrometry), FAD (flavin adenine dinucleotide), GC-MS (gas chromatography-mass spectrometry), GLC (gas-liquid chromatography), GMP (guanosine 5′-monophosphate), HPLC (high-performance liquid chromatography, high-pressure liquid chromatography), IC 50 (inhibitory concentration, 50%), IR (infrared), LC (liquid chromatography), LC/MS (liquid chromatography/mass spectrometry), LD 50 (50% lethal dose), mRNA (messenger RNA), MS (mass spectrum), NMR (nuclear magnetic resonance), OTC (over the counter), PCR (polymerase chain reaction), QOL (quality of life), RNA (ribonucleic acid), RT-PCR (reverse transcription polymerase chain reaction), TLC (thin-layer chromatography), tRNA (transfer RNA), UV (ultraviolet), WHO (World Health Organization)
Units
The following units should be used: length (m, cm, mm, μm, nm, Å), mass (kg, g, mg, μg, ng, pg, mol, mmol, μmol), volume (L, mL, μL), time (s, min, h, d), temperature (°C, K), radiation (Bq, dpm, Gy, Sv), and concentration (m, mm, mol/L, mmol/L, mg/mL, μg/mL, %, % (v/v), % (w/v), ppm, ppb) , 6.80; N, 4.50. Found: C, 73.30; H, 6.88; N, 4.65 .
Spectral and Elemental Analysis Data
Nomenclature
The nomenclature used for chemical compounds shall be in accordance with the nomenclature rules formulated by IUPAC. Alternatively, naming may conform to the nomenclature in the index of Chemical Abstracts or the Ring Index.
6. References and Notes "References" include articles published in journals, books, on the Internet, and others (technical reports, patents, lectures, etc.). References other than those indicated above should be described in the text. References should be numbered consecutively according to the order of citation in the text (one Arabic number should be assigned to each reference or note). An Arabic number followed by a right-hand half-parenthesis should be placed after the last relevant word in the sentence, outside the punctuation mark if any, and all references should be listed in numerical order at the end of the text in the section entitled References and Notes. Journal abbreviations should conform to those listed by Chemical Abstracts (cf. The ACS Style Guide. A Manual for Authors and Editors).
Examples of references are as follows: 1) Roques B. P., Florentin D., Callanquin M., J. Heterocycl. Chem., 12, 195-196 (1975) .
2) Cruickshank R., Duguid I. P., Marmion B. P., Swain R. H. A., "Medical Microbiology," 12th ed., Vol. III, Churchill Livingstone, New York, 1975. 3) Szejtli J., "Cyclodextrin Technology," ed. by Davis J. E. D., Kluwer Academic, Dordrecht, 1988. 4) Tokuda H., Ichiishi E., Onozuka M., Yamaguchi S., "Biology of Nitric Oxide, Part 6," Vol. I, Chap. 2, ed. by Moncada S., Tada N., Maeda H., Portland Press, London, 1998, pp. 185-186. 5) Brunner A., Greune H., U. S. Patent 1910462 (1993) [Chem. Abstr., 27, 4092-4096 (1993) ]. 6) Based on a lecture presented at the 30th Symposium on Heterocyclic Chemistry, Tokyo University of Pharmacy & Life Science, Hachioji, on 25 November, 1999. 7) International Organization for Standardization. "How ISO develops standards.": 〈http://www.iso.org/iso/about/how_ iso_develops_standards.htm〉 , cited 25 August, 2008. In the References section, include the last names and initials of the first and middle names for all authors. For references appearing in the main text, the last names of the first 2 authors only should be written. For references with 3 or more authors, write the name of the first author followed by et al. (Example: Jones et al.) .
Ⅳ. X-RAY CRYSTAL STRUCTURE ANALYSES
When structure determination by X-ray crystallographic analysis is a central theme of a paper, the data required for registration with the Cambridge Crystallographic Data Centre (CCDC) should be attached as supplementary material. Although this does not apply in cases where crystallographic analysis plays only a supplementary role, crystal data (unit cell parameters, space group, Z density) and R-factor should still be noted. Atomic coordinates will be printed when the structure is important. Bond lengths and angles, thermal parameters, and torsion angles will be printed when they are important for the issues addressed in the paper. When papers have been accepted, the authors are advised to register the data with CCDC.
Ⅴ. NUCLEOTIDE SEQUENCES
Newly reported nucleotide sequences must be deposited in one of the data banks, (either DDBJ, GenBank, or EMBL) and an accession number must be obtained before the paper will be accepted by the Editorial Board. Access to the information in the database must be available at the time of publication. A footnote will be included in the paper indicating that such a deposit has been made.
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